Progentec Diagnostics is an Oklahoma City-based developer of technological innovations in the field of diagnostics. The company is committed to exploring and commercializing state of the art diagnostic interventions along with digital and social.
Progentec Diagnostics was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need.
Progentec Diagnostics was founded in 2015 and is based in Oklahoma City, Oklahoma.
Progentec Diagnostics is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics.
Progentec’s technologies include accurate bio-marker based tests to diagnose disease before symptoms begin to show, as well as tests to monitor and predict disease activity levels in Lupus.
Progentec has a comprehensive solution that synthesizes the synergies between advanced biologic markers and large amounts of digital markers captured through unique social media and mobile app interactions with lupus patients and other users.
Progentec has already established a popular lupus portal and a mobile app that is one of the most widely used social media and digital app in the US today. They have established access to nearly 65,000 users and the user base is growing rapidly.
Progentec Diagnostics is backed by Mayo Clinic Ventures, i2E, OCA Ventures, & NMC Lifesciences. The company has acquired LupusCorner, a patient-empowerment platform for people with systemic lupus erythematosus (SLE) and lupus nephritis.